Alison Bauerlein - 14 Jun 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 14 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2022, 16:12:35 UTC
Prior SEC filing: 09 May 2022
Next SEC filing: 17 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Stacie S. Aarestad, Attorney-in-Fact

Key filing fact

Alison Bauerlein filed Form 4 for Pear Therapeutics, Inc. on 16 Jun 2022.

Key facts

This page summarizes Alison Bauerlein's Form 4 filing for Pear Therapeutics, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2022, 16:12.

Change

Previous filing in this sequence was filed on 09 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PEARQ transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 14 Jun 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.

Footnote F2

The restricted stock units shall vest and settle as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a "separation from service" within the meaning of Section 409A of the Internal Revenue Code (the "Separation Date"), provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested).